Nonsensical update to PR: "39% (11 SAEs in 28 Pati
Post# of 148168
(Total Views: 747)
Posted On: 07/21/2020 11:59:44 AM
Nonsensical update to PR: "39% (11 SAEs in 28 Patients) in Placebo Arm as Compared to Only 14% (8 SAEs in 56 Patients) in Leronlimab Arm Reported Serious Adverse Events (SAEs)"
39% of what?
It is sloppy to botch the initial PR but to botch the correction too? Wow.
39% of what?
It is sloppy to botch the initial PR but to botch the correction too? Wow.
(4)
(2)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼